These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva. Alessi Wolken DM; Idone V; Hatsell SJ; Yu PB; Economides AN Bone; 2018 Apr; 109():210-217. PubMed ID: 28629737 [TBL] [Abstract][Full Text] [Related]
6. Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva. Barruet E; Hsiao EC Bone; 2018 Apr; 109():162-167. PubMed ID: 28716551 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification. Yamamoto M; Stoessel SJ; Yamamoto S; Goldhamer DJ J Bone Miner Res; 2022 Nov; 37(11):2077-2093. PubMed ID: 35637634 [TBL] [Abstract][Full Text] [Related]
8. TGF-Beta Induces Activin A Production in Dermal Fibroblasts Derived from Patients with Fibrodysplasia Ossificans Progressiva. de Ruiter RD; Wisse LE; Schoenmaker T; Yaqub M; Sánchez-Duffhues G; Eekhoff EMW; Micha D Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768622 [TBL] [Abstract][Full Text] [Related]